( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical, Medical & Biological Sciences

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

European Journal of Pharmaceutical and Medical Research (EJPMR) has indexed with various reputed international bodies like : Google Scholar , Indian Science Publications , InfoBase Index (In Process) , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , International Society for Research activity (ISRA) , Scientific Indexing Services (SIS) , Polish Scholarly Bibliography , Global Impact Factor (GIF) (Under Process) , Universal Impact Factor , International Scientific Indexing (ISI), UAE  , Index Copernicus , CAS (A Division of American Chemical Society) USA (Under Process) , Directory of Open Access Journal (DOAJ, Sweden, in process) , UDLedge Science Citation Index , CiteFactor , Directory Of Research Journal Indexing (DRJI) , Indian citation Index (ICI) , Journal Index (JI, Under Process) , Directory of abstract indexing for Journals (DAIJ) , Open Access Journals (Under Process) , Impact Factor Services For International Journals (IFSIJ) , Cosmos Impact Factor , Jour Informatics (Under Process) , Eurasian Scientific Journal Index (ESJI) , International Innovative Journal Impact Factor (IIJIF) , Science Library Index, Dubai, United Arab Emirates , Pubmed Database [NLM ID: 101669306] (Under Process) , IP Indexing (IP Value 2.40) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , 

 ISSN 2394-3211

Impact Factor: 6.222

 ICV - 79.57



Dr. Md. Raknuzzaman*, Tasnim Jannaty, Dr. Anis Ahmed, Dr. Md. Shahidullah, Dr. Md. Masud Rana, Professor, Shaikh Amir Hossain


Background: Neurodegenerative disease is a feature of many debilitating, incurable diseases that are rapidly rising in prevalence, such Alzheimer's, Parkinson's, prion, Huntington's, as amyotrophic lateral sclerosis (ALS) spinocerebellar ataxia(SCA), spinal muscular atrophy(SMA) and some other diseases or disorders. In contrast to many other disease states, low serum uric acid (UA) levels are found in many neurodegenerative diseases. Aim of the Study: The aim of this study was to evaluate the Serum Uric Acid Level as a prognostic marker in several neurodegenerative diseases. Materials and Methods: This study was carried out at neuromuscular disorder clinic, inpatient and outpatient Department of Neurology, Bangabandhu Sheik Mujib Medical University (BSMMU) Dhaka, Bangladesh. The duration of the study was from January 2018 to December 2018. This case-control cross-sectional study included 37 patients with several neurodegenerative diseases such as Alzheimer's disease (n=9), Parkinson's disease (n=8), prion disease (n=8), Huntington's disease (n=7) and finally amyotrophic lateral sclerosis (ALS) (n=5) were finalized as the case. On the other hand, 37 healthy people without any type of neurodegenerative or cerebrovascular disease met the proper exclusion criteria were recruited as the control group participants from stable outpatients and medical staff of the mentioned hospital. Results: In analyzing the Serum UA level we found the mean (±SD) Serum UA level of case and control groups were 4.66 ± 1.15 and 5.42 ± 1.20 respectively where the p-value was 0.0069 which indicated a significant correlation between both the groups. Besides this, in a specific analysis of the Serum UA level of only Alzheimer's patients, we found it was 4.58 ± 1.02. Although the number of Alzheimer's patients was 9, the p-value was 0.0377. So there was also significant. So Serum Uric Acid Level played an important role as a prognostic marker in several neurodegenerative diseases. Conclusions: Serum Uric Acid levels played an important role as a prognostic marker in several neurodegenerative diseases. The findings may be helpful in the diagnostic system of several neurodegenerative diseases.

Keywords: Serum Uric Acid Level, Neurodegenerative diseases, Alzheimer's.

[Full Text Article]



  • New Issue Published

    Its Our pleasure to inform you that, EJPMR 1 November 2021 Issue has been Published, Kindly check it on


    NOVEMBER Issue has been successfully launched on 1 November 2021.

  • EJPMR New Impact Factor

    Its our Pleasure to Inform you that EJPMR Impact Factor has been increased from  5.804 to 6.222, due to high quality Publication at International Level

  • Index Copernicus Value

    EJPMR Received Index Copernicus Value 79.57, due to High Quality Publication in EJPMR at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.


  • Article Invited for Publication

    Article are invited for publication in EJPMR Coming Issue

Google Scholar Indian Science Publications InfoBase Index (In Process) SOCOLAR, China Research Bible, Fuchu, Tokyo. JAPAN International Society for Research activity (ISRA) Scientific Indexing Services (SIS) Polish Scholarly Bibliography Global Impact Factor (GIF) (Under Process) Universal Impact Factor International Scientific Indexing (ISI), UAE Index Copernicus CAS (A Division of American Chemical Society) USA (Under Process) Directory of Open Access Journal (DOAJ, Sweden, in process) UDLedge Science Citation Index CiteFactor Directory Of Research Journal Indexing (DRJI) Indian citation Index (ICI) Journal Index (JI, Under Process) Directory of abstract indexing for Journals (DAIJ) Open Access Journals (Under Process) Impact Factor Services For International Journals (IFSIJ) Cosmos Impact Factor Jour Informatics (Under Process) Eurasian Scientific Journal Index (ESJI) International Innovative Journal Impact Factor (IIJIF) Science Library Index, Dubai, United Arab Emirates Pubmed Database [NLM ID: 101669306] (Under Process) IP Indexing (IP Value 2.40) Web of Science Group (Under Process) Directory of Research Journals Indexing Scholar Article Journal Index (SAJI) International Scientific Indexing ( ISI )